The University of Minnesota is expanding access to clinical trials and supporting the health research community by sharing its clinical trial resource, StudyFinder, with other institutions designated with Clinical and Translational Science Awards (CTSA), a program spearheaded by the National Institutes of Health (NIH). StudyFinder is an online tool pooling clinical trials and research studies in one space, with easy-to-understand language and functions. It helps patients and healthy volunteers get involved and allows researchers to publicize their clinical trials and connect with study volunteers.
Penn State University
See the following -
10 of Today's Really Cool Network & IT Research Projects
University at Buffalo and Northeastern University researchers are developing hardware and software to enable underwater telecommunications to catch up with over-the-air networks. This advancement could be a boon for search-and-rescue operations, tsunami detection, environmental monitoring and more. Sound waves used underwater are just no match for the radio waves used in over-the-air communications, but the researchers are putting smart software-defined radio technology to work in combination with underwater acoustic modems...
- Login to post comments
Open-source Code Leads to the Adoption of University of Minnesota's StudyFinder by Additional Translational Medicine Research Institutions
- Login to post comments
You Won't Believe the Outrageous Ways Big Pharma Has Bribed Doctors to Shill Drugs
At the 2010 meeting of the American Psychiatric Association in New Orleans, a psychiatrist from the East coast shared her anger with me about the recent clamp down on Pharma financial perks to doctors. Before news organizations and the 2010 Physician Financial Transparency Reports (also called the Sunshine Act, part of the Affordable Care Act) reported the outrageous amount of money Pharma was giving doctors to prescribe its new, brand-name drugs, there was almost no limit to what was spent to encourage prescribing...
- Login to post comments